US stock · US markets · public data

LH

Labcorp Holdings Inc · Healthcare

Reference price$317.75Updated according to the public source
P/E26.28
P/B2.99
ROE11.73%
DY 12M0.91%
Net margin—
Net debt/equity—
Market capUS$ 25.8 B
Volume (shares)197,975
SectorHealthcare
Overview

About LH

Demonstrações públicas consolidadas + SEC Company Facts

Labcorp Holdings Inc (LH) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
06/24
09/24
03/25
06/25
09/25
03/26
06/26
Income in shown records$5.04
DY 12M0.91%
Records shown7
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo pago$0.72
Period ending 2026-03-31Dividendo pago$0.72
Period ending 2025-09-30Dividendo pago$0.72
Period ending 2025-06-30Dividendo pago$0.72
Period ending 2025-03-31Dividendo pago$0.72
Period ending 2024-09-30Dividendo pago$0.72

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$12,161,600,000.00$13,008,900,000.00$13,951,700,000.00—
Gross Profit$3,364,900,000.00$3,624,400,000.00$4,012,500,000.00—
Operating Income$725,600,000.00$1,086,700,000.00$1,384,700,000.00—
Net Income$418,000,000.00$746,000,000.00$876,500,000.00—
EPS Diluted$4.77 / share$8.84 / share$10.46 / share—

Balance sheet

Account2023202420252026
Total Assets$16,725,100,000.00$18,379,000,000.00$18,392,700,000.00—
Total Liabilities$8,834,600,000.00$10,312,500,000.00$9,756,000,000.00—
Total Equity$7,875,000,000.00$8,052,200,000.00$8,619,800,000.00—
Long-term Debt$4,054,700,000.00$5,331,200,000.00$5,084,600,000.00—
Current Debt—$1,000,300,000.00$500,100,000.00—
Shares Outstanding88,500,000 shares84,100,000 shares83,700,000 shares82,400,000 shares
Cash & Investments$536,800,000.00$1,518,700,000.00$532,300,000.00—
Dívida Líquida—$4,812,800,000.00$5,052,400,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow$1,327,700,000.00$1,585,800,000.00$1,640,500,000.00—
Capital Expenditures$453,600,000.00$489,900,000.00$434,500,000.00—
Dividends Paid$254,000,000.00$243,100,000.00$240,700,000.00—
Free Cash Flow$874,100,000.00$1,095,900,000.00$1,206,000,000.00—
FAQ

Frequently asked questions

What is the price of LH?

The reference price available for LH is $317.75.

What is the P/E of LH?

The P/E ratio of LH is 26.28. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of LH?

The P/B of LH is 2.99. This compares price with reported book value per share.

What is the ROE of LH?

The ROE (Return on Equity) of LH is 11.73%. This relates the reported net result to shareholders' equity.

What is the dividend yield of LH?

The dividend yield of LH is 0.91%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of LH?

The market capitalization of LH is US$ 25.8 B.

What sector is LH in?

LH operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.